Jianpi Lizheng Powder Veterinary Grade API is typically introduced into feed manufacturing lines as a brown-to-tan botanical powder with an irregular, fiber-containing particle morphology. In premix applications, the first unit operation is de-agglomeration through an inline sieve with a 0.5–0.8 mm aperture, followed by ferrous metal removal with an 8000–10000 gauss magnetic separator and controlled weighing. The sifted powder is not added directly to complete feed but is built into a 5.0% or 10.0% w/w intermediate premix by sequential dilution in a horizontal ribbon mixer at 60–70% working volume. The process order is as follows: a 1:5 w/w dilution stage is mixed for 8–12 minutes at 15–20 rpm, and a subsequent 1:20 or 1:25 w/w stage is mixed for 6–10 minutes at the same speed. Ribbon tip speed is maintained below 2.5 m/s to minimize fracture of brittle botanical particles and to avoid generating fines below 150 µm. Batch homogeneity acceptance is set at a coefficient of variation no greater than 5.0% across 10 sampling points, with sampling performed according to ISO 6497:2002. The final premix is discharged into weighed bags, sealed, and stored below 25°C and 60% relative humidity; under these conditions, microbial load is monitored using USP <61> and USP <62>, while loss on drying is measured by USP <731>. Because the resulting premix is an animal feed ingredient, the production line falls under FDA 21 CFR Part 507 and EU Regulation 1831/2003 where applicable. Carrier selection for this operation is the main process control variable because carrier density, particle size, and moisture determine whether the active powder remains homogeneously distributed during transport and bulk storage. Calcium carbonate carriers with a bulk density of 900–1200 g/L are used when the premix is intended for mineral feed, whereas rice husk meal and corn cob meal with a bulk density of 280–450 g/L are used for organic feed carriers. If the density difference between the API and the carrier exceeds 250 g/L, flow segregation occurs in bins and auger systems, especially when the mixture is transferred by pneumatic conveying. The measured moisture content of the finished premix should remain below 6.0% when stored for more than 30 days; if the carrier moisture exceeds 10.0%, caking and mold growth may occur before the active powder is added. High-moisture molasses carriers are incompatible with this material unless the batch is consumed within 24 hours, because free water binds the botanical fines into hard lumps that cannot be redispersed. The final premix is used as a feed additive for oral administration in swine and poultry lines, metered at the mill with a screw feeder calibrated for a defined inclusion rate, and then mixed with complete feed for 3–5 minutes in a horizontal paddle mixer.

For drinking-water administration, the same API is reformulated into dispersible granules by top-spray fluid-bed granulation rather than being issued as the raw powder. The granulation bowl is charged with the API and a diluent selected from lactose monohydrate or maltodextrin at a ratio of 1:1 to 1:3 w/w; a binder solution containing 3.0–5.0% povidone K30 or 10.0–15.0% maltodextrin is sprayed at 20–30 g/min per kg of dry charge. Inlet air temperature is set to 60–70°C, product temperature is held in the 35–42°C range, and atomization pressure is controlled between 1.0 and 1.5 bar. The endpoint is a granule with a median particle size of 150–250 µm and a fines fraction below 75 µm of less than 15.0% to limit dust during packaging. These granules are then filled into single-dose aluminum-laminated sachets or bulk containers for field dilution. A dispersion test at 25°C in tap water is used for batch release, with a target of dispersion rather than complete dissolution because the botanical matrix contains water-insoluble fiber; if the aggregated sediment exceeds 10.0% by volume after 5 minutes, the batch is rejected or reformulated with 0.1–0.3% xanthan gum and re-granulated. The finished drinking-water product is applied through an automated dosing pump calibrated to deliver 0.1–1.0 L/h into a header tank; the target in-use suspension is consumed within 4–6 hours to avoid settling and microbial growth in the water line. Biofilm control in the dosing line is separate from the product; lines are cleaned with 0.5% sodium hypochlorite and flushed before each new batch.

What Limits Aqueous Granulation of Veterinary Herbal Powders for Tablet Compression?

Tablet production from Jianpi Lizheng Powder Veterinary Grade API is constrained by the high botanical loading required in the core and by the hygroscopic nature of the milled material. In a direct compression trial, a 60–80% w/w drug load frequently produces Carr index values above 25 and angle of repose above 40°, which leads to die filling variation and tablet weight RSD greater than 5.0% on a rotary press. Aqueous granulation is therefore used when the tablet specification requires disintegration within 15 minutes in water at 37°C according to USP <701>. The binder system is typically prepared as a 5.0% w/w aqueous solution of povidone K90 or a 5.0–10.0% w/w starch paste; the granulating liquid is added to the high-shear mixer at 1.0–2.0% of the dry charge per minute. The granulator impeller is run at 200–300 rpm and the chopper at 1500–2000 rpm, with a wet mass time of 3–6 minutes after binder addition. Over-granulation must be avoided because the sheared botanical fibers absorb water and form a sticky, paste-like mass that cannot be extruded or milled. The wet granules are transferred to a fluid-bed dryer and dried at an inlet temperature of 55–60°C, with a product temperature limit of 40°C to reduce thermal degradation of heat-sensitive constituents. The acceptable moisture endpoint is 2.0–4.0% by USP <731>. Granules above 1.2 mm are milled through a cone mill with a round-hole screen, and the retained fraction above 850 µm is recycled. The lubricated blend is then compressed on a rotary tablet press equipped with a precompression station. Precompression force is set at 5.0–10.0 kN and main compression force at 12.0–20.0 kN; turret speed is limited to 30–50 rpm for multi-punch tooling to reduce capping. Tablet hardness is controlled between 60 and 80 N for standard oral tablets, and friability is not more than 1.0% per USP <1216>. If the granule moisture falls below 1.5%, lamination occurs because dry botanical fibers recover elastically after compression; if it exceeds 4.0%, punch sticking and capping increase. Chewable veterinary tablets can be produced with a lower hardness range of 40–60 N and contain a sweetener matrix, but in such cases the disintegration specification is replaced by a masticatory release profile. Tablet cores are coated with hydroxypropyl methylcellulose or a natural polysaccharide film to protect odor and moisture; pan coating is conducted at 35–45°C with a spray rate of 5–10 g/min per kg of tablet charge. Published data for this specific API in a tablet matrix are limited outside manufacturer in-house development reports; the ranges described here reflect standard high-herb-loading tableting practice.

Capsule Filling and Powder Flow Modification

Encapsulation of Jianpi Lizheng Powder Veterinary Grade API is normally performed after dry granulation or roller compaction because the raw powder has poor flow and a high fiber content. On a tamping-pin capsule filler, raw powder fill weight variation may exceed 7.5% RSD, which is outside the acceptance zone for content uniformity; after roller compaction, the same material can be conditioned to Carr index at or below 20 and Hausner ratio at or below 1.25. The dry granulation step uses a roll pressure of 5.0–8.0 MPa and a roll speed of 5–10 rpm, with an oscillating screen aperture of 0.8–1.2 mm. The granulated material is then blended with 0.2–0.5% colloidal silicon dioxide as a glidant and 0.25–1.0% magnesium stearate as a lubricant in a bin blender at 10–15 rpm for 3–5 minutes. The fill blend is loaded into a dosator or tamping-pin machine; tamping pin settings are selected to produce a slug height that does not exceed 70% of the capsule body length, because deeper compacts cause splitting of the formed plug. Size 0 and size 1 capsules are used for swine and poultry oral products, while size 2 and size 3 capsules are assigned for small companion animals, with fill weights from 150 to 500 mg. The filled capsule shell is sealed if a gelatin shell is used and stored at 20–25°C; if the shell is hydroxypropyl methylcellulose, storage at 40°C and 75% relative humidity for 6 months under VICH GL3 conditions is acceptable only when the fill moisture is below 6.0%. The botanical nature of the fill material creates a water activity limit: above 0.60, the gelatin shell can become brittle after moisture migration, while below 0.35 the shell may crack due to dehydration. Microbial quality of the fill is monitored by USP <61> and USP <62>, with acceptance limits appropriate for nonsterile oral veterinary dosage forms. Batch release includes fill weight variation of not more than 3.0% RSD for the finished capsules and disintegration time not more than 30 minutes in water at 37°C according to USP <701>. When the powder is filled without granulation, the addition of a hydrophobic glidant above 0.5% is avoided because it can coat the botanical particles and delay wetting in the dissolution medium.

When the API Is Specified for Injectable Solutions Rather Than Oral Solids

Formulation of Jianpi Lizheng Powder Veterinary Grade API as an injectable solution is not a routine downstream route and imposes additional purification requirements that are absent in oral dosage forms. The raw powder contains botanical fibers, lignin-like cell wall fragments, polysaccharides, and microbial residues; these must be removed before a solution can be filtered through a 0.22 µm membrane. A documented failure mode in pilot-scale batches is filter blinding within the first 10 minutes of filtration when a crude water extract is passed through a polyvinylidene fluoride capsule filter. To avoid this, the extraction is carried out in purified water at 80–90°C for 60–120 minutes, followed by continuous centrifugation at not less than 10,000×g and ultrafiltration through a 10 kDa molecular-weight cutoff membrane. The clarified permeate is then adjusted to pH 5.0–7.0 with 0.1 N hydrochloric acid or 0.1 N sodium hydroxide, and osmolality is adjusted to 285–310 mOsm/kg with sodium chloride or mannitol if isotonicity is required. Sterility is evaluated by membrane filtration according to USP <71>, and bacterial endotoxins are tested with USP <85>; an endotoxin limit of not more than 0.5 EU/mg is typical for injectable botanical intermediates, although the final acceptance limit must be justified by dose. Terminal sterilization at 121°C for 15 minutes is suitable only if the solution contains no heat-labile precipitate after a pilot thermal challenge; otherwise aseptic filling through a 0.22 µm sterilizing-grade filter is required. The injectable solution must be filled into Type I glass ampoules or vials under nitrogen or vacuum because oxygen accelerates browning of phenolic constituents. Storage at 2–8°C is generally required once the solution is sterilized, and a shelf life of 12–18 months is common for similar botanical injectables. Published data for this specific veterinary API in injectable form is limited; therefore line clearance, filter validation, and batch-specific stability are obligatory before commercial use.

Selecting Dry Binders for Direct Compression of Veterinary Granules

Dry granulation offers a route to finished granules and sachet products when aqueous granulation introduces unacceptable microbial load or loss of active constituents. The roller compaction process for Jianpi Lizheng Powder Veterinary Grade API is designed by setting the roll gap to 1.5–2.0 mm and roll pressure to 5.0–8.0 MPa; the ribbons are milled through a 0.8–1.2 mm oscillating sieve, and the fraction between 150 and 850 µm is collected as product. A ribbon density of 1.1–1.4 g/cm³ is targeted because lower density ribbons produce excessive fines, while higher density ribbons produce granules that are too hard to disperse in water. The dry granule is then blended with 0.3–0.5% colloidal silicon dioxide and 0.2–0.5% magnesium stearate before packing into single-dose sachets. For direct administration, the granule can be mixed with dextrose, mannitol, or sodium chloride to adjust bulk density and to provide a carrier that dissolves quickly in water. The final sachet product is controlled by sieve analysis according to ISO 2591-1; the acceptance range is 90.0% between 150 and 850 µm, with not more than 5.0% below 75 µm. Moisture content is held below 5.0% by USP <731> to prevent compaction of the sachet contents during storage. If the product is packaged in aluminum-laminated film, the water vapor transmission rate of the film should be below 0.1 g/m²/day at 38°C and 90% relative humidity; otherwise moisture uptake raises the Carr index above 25 in as little as 4 weeks. The dry granulation approach is particularly appropriate for tropical distribution chains where temperature and humidity exceed 40°C and 75% relative humidity, because the water-free process eliminates the drying step and reduces the risk of Maillard browning. However, the roller compactor cannot be operated at roll speeds above 10 rpm without reducing ribbon quality, and the resulting lower throughput must be balanced against the stability advantage.

Because the water-insoluble fraction of the API must remain suspended during automated dosing, liquid premix operations use a preserved suspension rather than a true solution. The manufacturing sequence is high-shear dispersion in purified water with 0.1–0.3% xanthan gum or 0.5–1.0% sodium carboxymethylcellulose as a suspending vehicle; the suspension is homogenized in a rotor-stator mixer at 3000–5000 rpm for 10–15 minutes. The pH is adjusted to 4.0–5.5 because weakly acidic conditions inhibit bacterial growth and reduce the oxidation of phenolic components. Preservatives used include potassium sorbate at 0.1–0.2% or sodium benzoate at 0.1–0.3%, but compatibility with the suspending polymer must be confirmed in a three-day accelerated sedimentation test at 40°C. The suspension is filled into high-density polyethylene bottles with a headspace of not more than 10.0% of the bottle volume; this limits oxygen ingression during storage. Physical stability is assessed by measuring the volume of clear supernatant after 24 hours; a settled bed that cannot be redispersed with 10 manual inversions is a rejection criterion. In automated dosing systems, the suspension is stirred at 60–120 rpm; peristaltic pump lines are calibrated before each batch because the viscosity of the liquid changes from 500 to 1500 mPa·s at shear rates below 0.1 s⁻¹. The product is administered via drinking water or milk replacer at a defined dilution ratio, and the diluted mixture is consumed within 2–4 hours. Residues left in the dosing line are flushed with 0.2 N citric acid solution to prevent pellicle formation, followed by potable water. This liquid dosage form is suitable only for short-duration use; long-term storage beyond 6 months is not recommended without specific real-time stability data because the botanical suspension can develop color shifts and changes in particle settling behavior. If published data for this specific API in a preserved suspension are limited, the formulation is treated as a development-grade product and subjected to VICH GL3 stability protocols before batch release.